agilon health, inc.
AGL
$0.43
-$0.01-1.68%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.14% | -1.05% | -5.92% | -4.45% | 44.20% |
| Total Other Revenue | -22.73% | -10.85% | -7.42% | -8.10% | 27.99% |
| Total Revenue | 3.09% | -1.08% | -5.92% | -4.46% | 44.16% |
| Cost of Revenue | 6.37% | -0.80% | -0.22% | -3.09% | 35.61% |
| Gross Profit | -137.01% | -5.42% | -262.94% | -32.45% | 59.68% |
| SG&A Expenses | -1.92% | -15.51% | -18.30% | -11.59% | -7.39% |
| Depreciation & Amortization | 7.31% | 19.49% | 23.90% | 17.66% | 37.15% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.07% | -1.29% | -0.94% | -3.40% | 33.33% |
| Operating Income | -49.43% | 3.69% | -172.88% | -353.18% | 36.30% |
| Income Before Tax | -79.18% | 5.54% | -244.88% | -154.34% | 37.27% |
| Income Tax Expenses | -24.64% | 43.90% | -85.13% | 247.37% | 558.05% |
| Earnings from Continuing Operations | -77.47% | 5.35% | -240.39% | -158.15% | 36.32% |
| Earnings from Discontinued Operations | -100.00% | -- | -- | 250.85% | 101.01% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -100.00% |
| Net Income | -78.54% | 6.30% | -240.17% | 299.74% | 54.09% |
| EBIT | -49.43% | 3.69% | -172.88% | -353.18% | 36.30% |
| EBITDA | -55.53% | 4.84% | -196.94% | -1,460.68% | 38.48% |
| EPS Basic | -77.48% | 6.96% | -238.07% | 297.97% | 54.72% |
| Normalized Basic EPS | -47.33% | 8.55% | -252.13% | -121.43% | 40.12% |
| EPS Diluted | -77.48% | 6.96% | -238.07% | 297.97% | 54.79% |
| Normalized Diluted EPS | -47.33% | 8.55% | -252.13% | -121.43% | 40.12% |
| Average Basic Shares Outstanding | 0.62% | 0.70% | 0.62% | 0.98% | 1.37% |
| Average Diluted Shares Outstanding | 0.62% | 0.70% | 0.62% | 0.98% | 1.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |